PPARdelta plays specific roles in embryo development and systemic lipid metabolism, but is not required for colorectal tumor establishment.
Answers are grounded in this paper and cite their sources.
PPARdelta's developmental and metabolic roles in mice warrant extreme caution for human targeting; leaves open its functions in clinical metabolism or colorectal neoplasia.
Targeting of the nuclear prostaglandin receptor peroxisome proliferator-activated receptor delta (PPARdelta) by homologous recombination results in placental defects and frequent (>90%) midgestation lethality. Surviving PPARdelta(-/-) mice exhibit a striking reduction in adiposity relative to wild-type levels. This effect is not reproduced in mice harboring an adipose tissue-specific deletion of PPARdelta, and thus likely reflects peripheral PPARdelta functions in systemic lipid metabolism. Finally, we observe that PPARdelta is dispensable for polyp formation in the intestine and colon of APC(min) mice, inconsistent with its recently proposed role in the establishment of colorectal tumors. Together, these observations reveal specific roles for PPARdelta in embryo development and adipocyte physiology, but not cancer.
No takes yet. Share an insight, caveat, or question.
Barak et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: